Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary Hypoplasia

NCT01240057 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2021-05-04

No results posted yet for this study

Summary

This trial investigates whether prenatal intervention improves survival rate of fetuses with isolated congenital diaphragmatic hernia and severe pulmonary hypoplasia, as compared to expectant management during pregnancy, both followed by standardized postnatal care.

Conditions

  • Congenital Diseases
  • Diaphragmatic Hernia
  • Pulmonary Hypoplasia

Interventions

PROCEDURE

fetal endoluminal tracheal occlusion

percutaneous fetoscopy, positioning of endoluminal balloon at 27-30 weeks and whenever possible elective removal at 34 weeks

OTHER

watchful waiting during pregnancy

pregnancy surveillance for fetal wellbeing, development of polyhydramnios and cervical shortening

Sponsors & Collaborators

  • King's College Hospital NHS Trust (UK)

    collaborator UNKNOWN
  • Hospital Clinic of Barcelona

    collaborator OTHER
  • Hopital Antoine Beclere

    collaborator OTHER
  • University Hospital, Bonn

    collaborator OTHER
  • Mater Mothers' Hospital

    collaborator OTHER
  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    collaborator OTHER
  • Ospedale Pediatrico Bambino Gesù, Rome (IT)

    collaborator UNKNOWN
  • Mount Sinai Hospital, Canada

    collaborator OTHER
  • National Center for Child Health and Development, Tokyo (JP)

    collaborator UNKNOWN
  • The University of Texas Health Science Center, Houston

    collaborator OTHER
  • Medical University of Warsaw

    collaborator OTHER
  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Jan Deprest, MD · Universitaire Ziekenhuizen KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2020-03-31
Completion
2020-12-31

Countries

  • United States
  • Australia
  • Belgium
  • Canada
  • France
  • Germany
  • Italy
  • Japan
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01240057 on ClinicalTrials.gov